Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome

The impact of extramedullary disease (EMD) in AML on the outcomes of allogeneic hematopoietic cell transplantation (alloHCT) is unknown. Using data from the Center for International Blood and Marrow Transplant Research (CIBMTR) we compared the outcomes of patients who had EMD of AML at any time prio...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Sagun D., Zhang, Mei-Jie, Wang, Hai-Lin, Akpek, Görgün, Copelan, Edward A., Freytes, César, Gale, Robert Peter, Hamadani, Mehdi, Inamoto, Yoshihiro, Kamble, Rammurti T., Lazarus, Hillard M., Marks, David I., Nishihori, Taiga, Olsson, Richard F., Reshef, Ran, Ritchie, David S., Saber, Wael, Savani, Bipin N., Seber, Adriana, Shea, Thomas C., Tallman, Martin S., Wirk, Baldeep, Bunjes, Donald W., Devine, Steven M., de Lima, Marcos, Weisdorf, Daniel J., Uy, Geoffrey L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527880/
https://www.ncbi.nlm.nih.gov/pubmed/25915806
http://dx.doi.org/10.1038/bmt.2015.82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527880/
https://www.ncbi.nlm.nih.gov/pubmed/25915806
http://dx.doi.org/10.1038/bmt.2015.82

Ejemplares similares